Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$211,719,802
+$39,392,615 QoQ
Shares Held
176,517
-5.8% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.49%
of 13F equity value
Holder Rank
#258
of 4,621 holders
Holding Since
Sep 2020
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Derivatives in LLY
reported options exposure · as of Sep 30, 2020CallValue
$0
CallShares
0
PutValue
$35,524,800
PutShares
240,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Holocene Advisors, LP holds $1,328,883,667 across 8 Drug Manufacturers - General names. LLY ranks #3 (15.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
2,429,349 | $460,653,157 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
3,216,892 | $406,422,135 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
176,517 | $211,719,802 | |
| 4 | NVS |
Novartis AG
|
1,037,332 | $162,570,671 | |
| 5 | MRK |
Merck & Co., Inc.
|
628,000 | $80,698,000 | |
| 6 | JNJ |
Johnson & Johnson
|
18,956 | $4,814,255 | |
| 7 | BIIB |
Biogen Inc.
|
4,793 | $1,035,575 | |
| 8 | ABBV |
AbbVie Inc.
|
3,855 | $970,072 |
All Filings in LLY
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $211,719,802 | 176,517 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $172,327,187 | 187,359 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $175,409,285 | 163,220 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $114,139,459 | 149,593 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $529,845,761 | 679,699 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $447,306,248 | 541,592 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $329,114,408 | 426,314 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $387,690,001 | 437,603 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $110,943,454 | 122,538 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $57,804,761 | 74,303 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $62,419,656 | 107,081 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $49,311,756 | 91,806 | Shares | Sole | 2023-11-14 | |
| 2021-09-30 | $42,308,027 | 183,112 | Shares | Sole | 2021-11-15 | |
| 2021-03-31 | $19,281,505 | 103,209 | Shares | Sole | 2021-05-17 | |
| 2020-09-30 | $35,524,800 | 240,000 | Put | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||